Heart Test Laboratories, Inc.

NasdaqCM HSCS

Heart Test Laboratories, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending October 31, 2024: USD -4.21 B

Heart Test Laboratories, Inc. Free Cash Flow is USD -4.21 B for the Trailing 12 Months (TTM) ending October 31, 2024, a -79,437.82% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Heart Test Laboratories, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending October 31, 2023 was USD -5.29 M, a 62.81% change year over year.
Heart Test Laboratories, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending October 31, 2022 was USD -14.23 M.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

NasdaqCM: HSCS

Heart Test Laboratories, Inc.

CEO	Mr. Andrew Simpson
IPO Date	June 16, 2022
Location	United States
Headquarters	550 Reserve Street
Employees	15
Sector	Health Care
Industries Medical Instruments Telehealth

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Key trends

Past 5 years